Ginkgo Spirig HC 240 mg
Ginkgo Spirig HC 240 mg is a medicine authorised by Swissmedic under authorisation number 68362. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Herbal medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 July 2022 and the authorisation is limited until 14 July 2027. ATC code N06DX02 places the medicine in the group Psychoanaleptics.
| Authorisation number | 68362 |
|---|---|
| Name | Ginkgo Spirig HC 240 mg |
| Full name | Ginkgo Spirig HC 240 mg, Filmtabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Herbal medicines |
| Dispensing category | B · Prescription only |
| ATC code | N06DX02 |
| First authorisation | 15 July 2022 |
| Authorisation validity | 14 July 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ginkgo Spirig HC 240 mg, Filmtabletten | B | 15 July 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N06DX02 | 02.97.0. | B |
| 2 | 60 | Tablette(n) | N06DX02 | 02.97.0. | B |
| 3 | 90 | Tablette(n) | N06DX02 | 02.97.0. | B |
| 4 | 120 | Tablette(n) | N06DX02 | 02.97.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ginkgo Spirig HC 240 mg authorised in Switzerland?
Yes. Ginkgo Spirig HC 240 mg is authorised by Swissmedic under authorisation number 68362, data as of 01 September 2026. The authorisation is limited until 14 July 2027.
Which dispensing category does Ginkgo Spirig HC 240 mg have?
Ginkgo Spirig HC 240 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ginkgo Spirig HC 240 mg?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.